Professional Documents
Culture Documents
Elderly people represent almost all patients diagnosed with and treated for rectal cancer, and this trend is likely to
become more apparent in the future. Surgical management and treatment decisions for this disease are becoming
increasingly complex, but only a few reports deal specically with older patients. In this systematic review, we provide
an overview of published studies of outcomes after curative surgery for rectal cancer in elderly people (>70 years). We
identied 48 studies providing information about postoperative results, survival, surgical approach, stoma formation,
functional results, and quality of life after rectal resection for cancer. We found that advanced chronological age
should not, by itself, exclude patients from curative rectal surgery or from other surgical options that are available for
younger patients. Although overall survival is lower in elderly patients than in younger patients, cancer-specic
survival does not decrease with age. However, the level of evidence for most studies was weak, emphasising the need
for high-quality clinical trials for this population.
Introduction
The incidence of rectal cancer increases with age, reaching
a peak at around the age of 80 years, with an age-specic
incidence of 135 new cases per 100 000 people per year
between 80 and 84 years of age.1 Thus, although people
older than 75 years account for only 510% of the overall
population in developed countries, 3545% of patients
with rectal cancer are in this age group.2,3 This proportion
may increase in the future because of demographics of an
ageing population, and increases in life expectancy.
Surgery is the cornerstone of curative therapy for
patients with rectal cancer. However, there is no
consensus about the optimum surgical management of
elderly people who are a heterogeneous group of patients,
ranging from very t to very frail individuals. This
population is undertreated compared with younger
patients. The percentage of patients operated upon
decreases with age,2,49 and the curative surgery rate is
substantially lower in older patients.4,7,8,1012 Additionally,
elderly people need more emergency surgery than do
younger patients.12,13 When curative surgery is planned,
neoadjuvant radiotherapy or chemoradiotherapy is less
discussed and used.2,3,6,8,9,12,1416 Usually, non-restorative
procedures such as Hartmanns procedure, abdominoperineal resection, or local excision are undertaken.
Anterior resections are done less often in elderly
patients,2,5,8,1113,15,17,18 although tumour location and stage
do not dier in elderly patients and younger patients.3,710
These disparities could be explained by patients
preferences, or by surgeons opinions about patients of
advanced age.
Elderly patients are generally recruited to clinical trials
less often than younger patients and therefore are
under-represented in publications about cancer treatment.19 They were not included in most trials that
assessed neoadjuvant therapy.20,21 Similarly, in most
colorectal cancer guidelines, routine screening is not
oered to patients older than 75 years.22 Because this
heterogeneous, fragile subset of patients with more
comorbidities and decreased reserve capacity was exwww.thelancet.com/oncology Vol 13 December 2012
Methods
Search strategy and selection criteria
Two authors (GM and MK) independently undertook
electronic literature searches with PubMed (Medline).
The search strategy applied was as follows: (elderly [Title/
Abstract] OR older [Title/Abstract] OR oldest [Title/
Abstract]) AND rectal neoplasms (MeSH).
We set an arbitrary age limit for considering a patient
as old at 70 years of age. We included only studies
published in English, in peer-reviewed journals, between
January, 1985, and April, 2012. We excluded editorials,
case reports, reviews, and letters or comments, and
studies that included both colon and rectal cancers
without a specic analysis of the results for rectal cancer.
We also excluded studies of palliative management
and neoadjuvant or adjuvant treatments. We identied
prospective and retrospective series and no study was
excluded on the basis of its type or size.
We then selected relevant articles from titles and
abstracts. The related articles function was used to
broaden the search. Further articles that were potentially
missed by the search strategy were identied by a manual
search of the references from the key articles.
Data analysis
GM and MK independently extracted data and assessed
quality. Disagreements were resolved by discussion.
The following topics were specically considered:
postoperative morbidity and mortality, postsurgical
survival, functional results and quality of life after
surgery, risk of permanent stoma, surgical approach,
type of bowel diversion, and place of local excision.
e525
Review
Results
Description of studies
48 studies met our selection criteria (gure), including
27 comparative retrospective studies, 13 cohort studies,
six non-comparative retrospective studies, and two
casecontrol studies. We identied no studies of bowel
diversion or place of local excision.
Long-term outcomes
48 studies included in the analysis
e526
174
(53%)
<75
years
276
(75%)
<80
years
154
(69%)
<75
years
NR
NR
626
833
61
78
77
70
741
(26%)
1383
(49%)
75
79
years
65
74
years
479
(78%)
75
years
NR
NR
244
(57%)
182
(43%)
60
69
years
64
70
years
133
(22%)
>75
years
80
82
504
(18%)
80
84
years
88
212
(8%)
85
years
69
(31%)
75
years
92
(25%)
80
years
157
(47%)
75
years
NR
NR
244
353
NR
NR
NR
NR
39
NR
NR
75
274
001
<005
NR
NR
NR
81
98
NR
NR
NR
NR
13
NR
NR
64
0482
021
NR
p
value
NR
NR
23
105
NR
NR
NR
NR
25
NR
NR
29
76
0001
NR
p
value
1
2
34
1
2
34
12
34
12
34
24
NR
NR
NR
NR
NR
NR
NR
NR
15
816 127
12
21
13
336
551
113
28
30
32
34
42
33
39
36
68
67
61
56
46
54
52
51
44
735 24
73
NR
NR
42
15
006
<0001
NR
006
NS
08
23
17
06
13
001
0178
0178
<0001
NS
026
NS
p value
Local p
(%)
value*
AR/ APR HM
LAR (%) (%)
(%)
729 143
<0001
NR
<0001
NR
p
value
30-day
mortality (%)
Surgery
75
706
218
NR
NR
NR
NR
NR
NR
84
16
67
33
NR
NR
p
value
Score %
Pulmonary
Cardiac
Neurological
ASA score
Number
of
patients
(%)
51
65
301
368
NR
NR
NR
NR
25
32
NR
NR
36
34
0007
0141
031
NS
p
value
Overall
25
75
NR
NR
NR
NR
NR
NR
CV
001
0014
NR
p
value
12
31
NR
NR
NR
NR
NR
NR
013
0127
NR
NR
72
31
NR
NR
NR
NR
13
NR
NR
AL
0168
NR
NR
p
value
NR
NR
p
value
Pulmonary
Review
e527
e528
29
(100%)
9737
(63%)
<75
years
125
(79%)
<75
years
1126
(83%)
<75
years
1126
(83%)
<75
years
574
(57%)
70
years
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
85
NR
NR
NR
NR
NR
NR
352
606
NR
NR
28
<005
NR
NR
NR
NR
NR
NR
24
91
NR
NR
NR
0106
NR
NR
NR
NR
NR
NR
32
NR
NR
NR
>0999
p
value
1
2
3
45
1
2
3
45
12
34
NR
NR
NR
NR
NR
NR
NR
100
100
NR
NR
66
60
81
73
NR
NR
NR
NR
19
27
691 192
NR
10
NR
NR
NR
NR
117
171 197
35
266
534
178
22
35
631
<0001
NR
NR
NR
NR
20
<0001
0292
<0001
NR
NR
NR
NR
25
78
26
91
<00001
<0001
p value
Local p
(%)
value*
AR/ APR HM
LAR (%) (%)
(%)
8
498
367
54
30
70
p
value
30-day
mortality (%)
Surgery
NR
NR
418
513
42
51
44
576
NR
NR
46
NR
0008
0165
p
value
Overall
NR
NR
31
87
NR
NR
08
61
NR
NR
NR
CV
NR
0111
p
value
NR
NR
69
117
NR
NR
24
NR
NR
NR
NR
>0999
p
value
Pulmonary
37
75
115
101
12
10
16
NR
NR
NR
AL
0008
NR
063
0507
p
value
Table 1: Postoperative results and morbidity and mortality after rectal cancer surgery in elderly patients in dierent age groups
Except where indicated, p values are for comparisons between elderly (the oldest age group) vs non-elderly patients (other age groups) in each study. ASA=American Society of Anesthesiologists. AR=anterior resection. LAR=low anterior resection.
APR=abdominoperineal resection. HM=Hartmanns procedure. CV=cardiovascular. AL=anastomotic leakage. NR=not reported. NS=not signicant. *p values are for comparisons between dierent types of rectal surgery between elderly and non-elderly
patient groups in each study. Median. Results for curative and palliative surgery. 1-year results. Non-comparative study. ||Comparison between elderly and non-elderly patients was only done for predictive factors for AL after rectal cancer resection.
425
(43%)
>70
years
230
(17%)
75
years
230
(17%)
75
years
33
(21%)
75
years
5606
(37%)
75
years
80
years
p
value
p
value
Score %
Pulmonary
Cardiac
Neurological
ASA score
Number
of
patients
(%)
Review
Review
Review
Number of
patients (%)
Mean age
(years)
Local recurrence
5-year DFS
Mollen et al (1997)
p value
012
33
75 years
48 (21%)
NR
5-year OS
p value
NS
66%
63%
90 (38%)
NR
22%
NR
49%
NR
18%
NR
53%
008
14%
NR
44%
75%
71%
327 (36%)
NR
18%
NR
60%
328 (36%)
NR
23%
NR
66%
75 years
157 (47%)
78*
NR
<75 years
174 (53%)
61*
NR
NR
NR
<80 years
103 (86%)
NR
NR
NR
72 (23%)
NR
NR
<80 years
240 (77%)
NR
NR
NR
NR
<75 years
154 (69%)
NR
NR
71%
01
53%
NR
77%
NR
NR
0002
40%
NR
57%
59%
001
43%
69%
008
50%
04
60%
NR
NR
66%
NR
075
69%
75 years
002
51%
NR
80 years
70%
>80 years
06
60%
65%
70%
0057
NR
NR
NR
343%
396%
8589 years
79 (36%)
NR
NR
NR
NR
8084 years
103 (47%)
NR
NR
NR
NR
048
NR
1564 years
39 (17%)
56%
<0001
6574 years
357%
<00001
402 (16%)
NR
NR
NR
243%
NR
6579 years
1265 (50%)
NR
NR
NR
449%
NR
5064 years
865 (34%)
NR
NR
NR
578%
0315
85 years
212 (8%)
88
17%
<0001
24%
NR
<0001
14%
NS
36%
8084 years
504 (18%)
82
14%
39%
28%
49%
7579 years
741 (26%)
77
12%
47%
38%
53%
6574 years
1383 (49%)
70
14%
133 (22%)
80*
NR
75 years
479 (78%)
64*
NR
NR
NR
6069 years
182 (43%)
NR
NR
NR
85*
NR
75 years
33 (21%)
NR
NR
<75 years
125 (79%)
NR
NR
NR
754%
<00001
44%
NR
0326
NR
NR
57%
NS
NR
67%
44%
NR
70%
25%
0061
675%
701%
63%
<0001
477%
NR
29 (100%)
51%
70 years
80 years
58%
p value
NS
42%
94 (41%)
90 years
NR
3564 years
247 (27%)
p value
8%
6574 years
75 years
5-year CSS
NR
0012
49%
71%
<005
75 years
3663 (377%)
80*
9%
NR
NR
73%
<75 years
6042 (623%)
65*
8%
NR
NR
78%
p values are for comparisons between elderly (the oldest age group) vs non-elderly patients (other age groups) in each study. DFS=disease-free survival. OS=overall survival.
CSS=cancer-specic survival. NR=not reported. NS=not signicant. *Median. Results for curative and palliative surgery. Non-comparative study.
Table 2: Long-term results after curative surgery for rectal cancer in elderly patients compared with younger patients
e530
Review
Review
controlled trials have assessed the benets of laparoscopic surgery for rectal cancer in elderly people, in
terms of both short-term and long-term results, quality
of surgery, functional outcomes, and quality of life. The
mean age of patients in published randomised trials that
included those with rectal cancer has never been greater
than 69 years.60
Only one comparative single-centre prospective study
specically reported the feasibility and short-term results
of laparoscopy in patients older than 75 years operated on
for rectal cancer between 2001 and 2008.59 It included
three groups: two groups operated by laparoscopy (group
A of 44 patients 75 years and group B of 228 patients
<75 years) and one group operated by laparotomy
(group C of 43 patients 75 years). In groups A and B, the
conversion rate into laparotomy and operating time were
similar. Blood loss was very low in both groups.
Oncological criteria (distal margin, circumferential
margin, and number of nodes harvested) did not dier
between the groups. Postoperative mortality and morbidity rates did not dier, although patients in group A
had a signicantly higher ASA score than did those in
group B. Similarly, time to atus and length of hospital
stay were similar. Between groups A and C, operative
time was signicantly longer for laparoscopy (256 min vs
202 min, p=00003). Blood loss was lower (25 mL vs
250 mL, p<00001) but the investigators did not undertake
an assessment of transfusion requirement. Postoperative
morbidity and mortality were identical, but resumption of
gastrointestinal function and length of stay were better
for patients in the laparoscopy group than for those in the
laparotomy group (13 days vs 37 days, p<00001; and
19 days vs 22 days, p=0002, respectively).
Two studies (one prospective comparison and one casecontrol study)57,58 analysed the laparoscopic approach for
colorectal surgery, and compared outcomes for elderly
patients and younger patients. In the multicentre study
by Scheidbach and colleagues,57 701 (15%) of 4823 patients
were operated on for rectal cancer (193 patients >75 years
and 508 <75 years). Postoperative mortality was higher in
elderly than in younger patients, but not signicantly so.
However, overall morbidity was higher in elderly patients
than in younger patients, mainly because of cardiopulmonary complications (93% vs 30%, p=0022) and
lung infections (72% vs 13%, p=0008), but not surgical
complications (haemorrhage 41% vs 25%, p=0485;
prolonged ileus 72% vs 38%, p=0257; anastomotic
leakage 134% vs 119%, p=0715). In Chauttard and
colleagues study, 75 patients aged 70 years and older
(including 27 undergoing rectal resection and 22 with
rectal cancer) were matched to 103 patients younger
than 70 years (including 34 undergoing rectal resection
and 24 with rectal cancer), according to body-mass
index, sex, ASA score, pathology and procedure
undertaken.58 For rectal resections, no signicant
intraoperative or postoperative dierence was detected
between the two groups.
www.thelancet.com/oncology Vol 13 December 2012
Review
Number
of
patients
(%)
ASA score
%
Scheidbach et al57 (2005)
>75 years
Number
of rectal
resections
(%)
Number Conversion
of rectal
cancers
(%)
p
value
p
value
Mean
operative time
Blood loss
Transfusion
Mortality
Morbidity
min
mL p
value
NS
p
value
p
value
p
value
NS
p
value
Days p
(SD) value
0007
909
(19%)
NR
NR
193
(212%)
58
(64%)
NR
NR
NR
5
(52%)
43
(443%)*
NR
NR
NR
508
(13%)
226
(58%)
NR
NR
NR
0 (0%)
67
(284%)*
NR
NS
NS
NS
NS
NS
70
years
75
(42%)
NR
27
(36%)
22
(29%)
3
(11%)*
266
81*
NR
3
(11%)*
0*
9
(33%)*
15
(11)*
<70
years
103
(58%)
NR
34
(33%)
24
(23%)
7
(20%)*
294
91*
NR
5
(13%)*
0*
15
(44%)*
15
(12)*
<00001
06066
0627
08006
00829
44
75 years
(16%)
(mean:
79 years)
1: 45%;
2: 818%;
3: 136%;
4: 0%
44
(100%)
44
(100%)
0
(0%)*
256*
25*
NR
0*
6
(136%)*
19*
1: 526%;
2: 461%;
3: 13%;
4: 0%
228
(100%)
228
(100%)
1
(04%)*
248*
33*
NR
0*
27
(118%)*
15*
p values are for comparisons between the elderly and non-elderly patient groups in each study. ASA=American Society of Anesthesiologists. NR=not reported. NS=not signicant. *Results for rectal surgery only.
Table 3: Postoperative results, morbidity, and mortality after laparoscopic rectal surgery for elderly and younger patients
Discussion
This systematic review has not addressed the global care
management of elderly patients with rectal cancer or the
indications for palliative surgery in this population. We
agree that multidisciplinary cooperation, involving
oncologists, gastroenterologists, radiotherapists, anaesthetists, radiologists, pathologists, and surgeons, is
essential in elderly patients. Furthermore, a comprehensive geriatric assessment is a major consideration in
assessment of operative risk, treatment decision making,
and adapting perioperative care if surgery is undertaken.
It will aim to identify any disability, undernutrition,
depression, polypharmacy, social or familial isolation, or
cognitive or functional disorder.61 In addition to biological
markers, this assessment needs to use validated scoring
systems. The Preoperative Assessment of Cancer in the
Elderly, which incorporates several questionnaires, could
be useful to identify suitable candidates for rectal
surgery.62,63 Added to this is a model integrating ve
variables (age, ASA score, operative urgency, cancer
resection, and metastatic disease) with a score of 045,
developed by the Association of Coloproctology of Great
Britain and Ireland for patients older than 80 years with
colorectal cancer, which could assist in patient selection
by predicting 30-day postoperative mortality, notably
after anterior resection or Hartmanns procedure.64
What emerges from this review is the scarcity of
evidence-based data for surgical rectal cancer management in elderly patients. The quality of most selected
www.thelancet.com/oncology Vol 13 December 2012
Review
Conclusion
No randomised trial of curative rectal cancer surgery in
elderly patients has been done. This systematic review
summarises the results of the few studies published so far
to assess applicability of established standard practices for
elderly people. Most standard practices and recommendations for rectal cancer can be extrapolated to elderly
patients. Rather than age itself, the frailty of patients and
preoperative anal sphincter function determine the
operative indication and type of surgery. To further
optimise surgical management, more studies are needed.
In particular, these studies should raise the question of the
most suitable type of diverting stoma for this population,
and the extension of indications for local excision (with or
without neoadjuvant or adjuvant chemoradiotherapy) for
patients with signicant comorbidities.
www.thelancet.com/oncology Vol 13 December 2012
Review
Contributors
MK contributed to study design, literature search, data analysis and
interpretation, and writing. GM contributed to literature search, data
analysis and interpretation, and writing. AW contributed to data analysis
and interpretation, and writing. NJM contributed to study design, data
analysis and interpretation, and writing. LH contributed to data analysis
and interpretation, and writing. All listed authors contributed equally to
the paper.
19
Conicts of interest
We declare no conicts of interest.
22
References
1
Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ,
Marijnen CA. Controversies of total mesorectal excision for rectal
cancer in elderly patients. Lancet Oncol 2008; 9: 494501.
2
Jung B, Pahlman L, Johansson R, Nilsson E. Rectal cancer
treatment and outcome in the elderly: an audit based on the
Swedish Rectal Cancer Registry 19952004. BMC Cancer 2009; 9: 68.
3
Elferink MA, Krijnen P, Wouters MW, et al. Variation in treatment
and outcome of patients with rectal cancer by region, hospital type
and volume in the Netherlands. Eur J Surg Oncol 2010;
36 (suppl 1): S7482.
4
Bouvier AM, Launoy G, Lepage C, Faivre J. Trends in the
management and survival of digestive tract cancers among patients
aged over 80 years. Aliment Pharmacol Ther 2005; 22: 23341.
5
Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S,
Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered
treatment and worse survival of elderly patients with colorectal
cancer. Br J Surg 2005; 92: 61523.
6
Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC,
Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer
have a higher risk of treatment-related complications and a poorer
prognosis than younger patients: a population-based study.
Eur J Cancer 2006; 42: 301521.
7
Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we
undertreating rectal cancer in the elderly? An epidemiologic study.
Ann Surg 2007; 246: 21521.
8
Endreseth BH, Romundstad P, Myrvold HE, Bjerkeset T, Wibe A.
Rectal cancer treatment of the elderly. Colorectal Dis 2006;
8: 47179.
9
Vironen JH, Sainio P, Husa AI, Kellokumpu IH. Complications and
survival after surgery for rectal cancer in patients younger than and
aged 75 years or older. Dis Colon Rectum 2004; 47: 122531.
10 Esnaola NF, Stewart AK, Feig BW, Skibber JM,
Rodriguez-Bigas MA. Age-, race-, and ethnicity-related dierences
in the treatment of nonmetastatic rectal cancer: a patterns of care
study from the national cancer data base. Ann Surg Oncol 2008;
15: 303647.
11 Kessler H, Hermanek P Jr, Wiebelt H. Operative mortality in
carcinoma of the rectum. Results of the German Multicentre Study.
Int J Colorectal Dis 1993; 8: 15866.
12 Barrier A, Ferro L, Houry S, Lacaine F, Huguier M. Rectal cancer
surgery in patients more than 80 years of age. Am J Surg 2003;
185: 5457.
13 Tan E, Tilney H, Thompson M, Smith J, Tekkis PP. The United
Kingdom National Bowel Cancer Project epidemiology and
surgical risk in the elderly. Eur J Cancer 2007; 43: 228594.
14 Eldin NS, Yasui Y, Scarfe A, Winget M. Adherence to treatment
guidelines in stage II/III rectal cancer in Alberta, Canada.
Clin Oncol (R Coll Radiol) 2012; 24: e9e17.
15 Puig-La Calle J Jr, Quayle J, Thaler HT, et al. Favorable short-term
and long-term outcome after elective radical rectal cancer resection
in patients 75 years of age or older. Dis Colon Rectum 2000;
43: 170409.
16 Smith JJ, Lee J, Burke C, Contractor KB, Dawson PM. Major
colorectal cancer resection should not be denied to the elderly.
Eur J Surg Oncol 2002; 28: 66166.
17 Rutten H, den Dulk M, Lemmens V, et al. Survival of elderly rectal
cancer patients not improved: analysis of population based data on
the impact of TME surgery. Eur J Cancer 2007; 43: 2295300.
18 Law WL, Choi HK, Ho JW, Lee YM, Seto CL. Outcomes of surgery
for mid and distal rectal cancer in the elderly. World J Surg 2006;
30: 598604.
23
20
21
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
e535
Review
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
e536
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.